Is Heparin-Induced Platelet Activation an Unrecognized Cause of Thrombosis in Chronic Dialysis Patients?

Abstract

Despite an increase in vaso-occlusive disorders and routine exposures to large quantities of heparin, chronic dialysis (CD) patients have not been studied for the presence of heparin-induced platelet activation (HIPA). Measurement of platelet aggregation and adenosine triphosphate release was performed at hepa rin concentrations of 0.1 U/mL and 100 U/mL using platelet-poor plasma (PPP) from 90 nonthrombocytopenic CD patients; 72 patients received heparin over prolonged periods (108 ±15 weeks); 18 patients received no heparin for two months prior to study.

Results: PPP from 1 hemodialysis (HD) patient stimulated strong ( > 19%) platelet activation at both 0.1 and 100 U/mL heparin concentrations. Four pa tients (4.4%) demonstrated intermediate (10-19%) platelet activation in the presence of 0.1 U/mL but not 100 U/mL heparin concentrations. Eighty-five patients demonstrated no platelet activation ( < 10%) at either heparin concen tration.

Conclusion: (1) None of the 90 dialysis patients met the strict laboratory criteria for HIPA. (2) Despite long-term exposure to large quantities of heparin, the prevalence of HIPA in CD patients appears to be no greater than that of the general patient population receiving heparin. (3) Nonthrombocytopenic HIPA is not a major factor contributing to thrombotic disorders in dialysis patients.

References

Weisman R. , Tobin R. : Arterial embolism occurring during systemic heparin therapy. Arch Surg 76:219-227, 1958.

Golub S. , Ulin A. : Heparin-induced thrombocytopenia in man. J Lab Clin Med 59:430-435, 1962.

Fidlar E. , Jacques L. : The effect of commercial heparin on the platelet count. J Lab Clin Med 33:1410-1423, 1984.

King D. , Kelton J. : Heparin-associated thrombocytopenia. Ann Int Med 100:535-540, 1984.

Phelan B. : Heparin-associated thrombosis without thrombocytopenia. Ann Int Med 99:637-638, 1983.

Kappa J. , Fisher C. , Berkowitz H. , et al: Heparin-induced platelet activation in sixteen surgical patients: Diagnosis and management. J Vasc Surg 5:101-109, 1987.

Hocking W. : Hematologic abnormalities in patients with renal diseases. Hem Onc Clin 1:229-260, 1987.

Kelton J. , Hirsch J. : Bleeding associated with antithrombotic therapy. Sem Hematol 17:259-291, 1980.

Fratantoni J. , Pollet R. , Gralnick H. : Heparin-induced thrombocytopenia: Confirmation of diagnosis with in vitro methods. Blood 45:395-401, 1975.

10.

Carvalho A. , Colman R. , Lees R. : Clofibrate reversal of platelet hypersensitivity in hyperbetalipoproteinemia . Circulation 50:570-574, 1974.

11.

Feinman R. , Lubowsky J. , Caro I. , et al: The Lumi-Aggregometer: A new instrument for simultaneous measurement of secretion and aggregation. J Lab Clin Med 90:125-129, 1977.

12.

Feinman R. , Detwiler T. , Ingerman-Wojenski C. : The platelets: Physiology and pharmacology. New York: Academic Press, 1985, pp 429-440.

13.

Kelton J. , Sheridan D. , Brian H. , et al: Clinical usefulness of testing for a heparin-dependent platelet-aggregating factor in patients with suspected heparin-associated thrombocytopenia. J Lab Clin Med 103:606-612, 1984.

14.

Sheridan D. , Carter C. , Kelton J. : A diagnostic test for heparin-induced thrombocytopenia . Blood 67:27-30, 1986.

15.

Rhodes G. , Dixon R. , Silver D. : Heparin induced thrombocytopenia with thrombotic and hemorrhagic manifestations . Surg Gynecol Obstet 136:409-416, 1973.

16.

Powers P. , Cuthbert D. , Hirsch J. : Thrombocytopenia found uncommonly during heparin therapy. JAMA 241:2396-2397, 1979.

17.

Ansell J. , Price J. , Shah S. , et al: Heparin-induced thrombocytopenia: What is its real frequency? Chest 88:878-882, 1985.

18.

Kapsch D. , Adelstein E. , Rhodes G. , et al: Heparin-induced thrombocytopenia, thrombosis, and hemorrhage . Surgery 86:148-155, 1979.

19.

Kakkasseril J. , Cranley J. , Panke T. , et al: Heparin-induced thrombocytopenia: A prospective study of 142 patients. J Vasc Surg 2:382-384, 1985.

20.

Bell W. , Tomasulo D. , Alving B. , et al: Thrombocytopenia occurring during the administration of heparin . Ann Int Med 85:155-160, 1976.

21.

Malcolm I. , Wigmore T. , Stembrecher U. : Heparin-associated thrombocytopenia: Low frequency in 104 patients treated with heparin of intestinal mucosal origin. Can Med Assoc J 120:1086-1088, 1979.

22.

Ingerman-Wojenski C: Simultaneous measurement of platelet aggregation and the release reaction on platelet-rich plasma and in whole blood. J Med Tech 1:697-701, 1984.

23.

Laster J. , Cricket D. , Walker N. , et al: The heparin-induced thrombocytopenia syndrome: An update. Surgery 102:763-770, 1987.

24.

Green D. , Harris K. , Reynolds N. , et al: Heparin immune thrombocytopenia: Evidence for a heparin-platelet complex as the antigenic determinant. J Lab Clin Med 91:167-175, 1978.

25.

Chong B. , Fawaz I. , Chesterman C. , et al: Heparin-induced thrombocytopenia: Mechanism of interaction of the heparin-dependent antibody with platelets. Br J Haematol 73:235-240, 1989.

26.

Cines D. , Tomaski A. , Tannenbaum S. : Immune endothelial cell injury in heparin-associated thrombocytopenia . N Engl J Med 316:581-589, 1987.

27.

Pfueller S. , Luscher E. : The effects of aggregated immunoglobulins on human blood platelets in relation to their complement-fixing abilities . J Immunol 109:517-525, 1972.

28.

Pfueller S. , David R. , Firkin B. , et al: Platelet aggregating IgG antibody to platelet surface glycoproteins associated with thrombosis and thrombocytopenia . Br J Haematol 74:336-341, 1990.

29.

Davis K. , Rifenberg M. , Smith M. , et al: Luminescence aggregometry in the diagnosis of heparin induced thrombocytopenia. Blood 70:338a, 1987.